Evidence map›Paper›PMID 22438574›Full record

ArticleDiabetes2012

Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes.

Jie Gao, Jinhan He, Xiongjie Shi, Maja Stefanovic-Racic, Meishu Xu, Robert Martin O'Doherty, Adolfo Garcia-Ocana, Wen Xie

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?International journal of environmental research and public health · 2020
    Review
  15. Article
  16. The Role of Sulfotransferases in Liver Diseases.Drug metabolism and disposition: the biological fate of chemicals · 2020
    Review
  17. Inhibition of Estrogen Sulfotransferase (Journal of the American Society of Nephrology : JASN · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jie GaoCenter for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Jinhan He
Xiongjie Shi
Maja Stefanovic-Racic
Meishu Xu
Robert Martin O'Doherty
Adolfo Garcia-Ocana
Wen Xie
University of Pittsburgh · US

Funding

The AHR-FGF221 Axis in Hepatic Steatosis and Metobolic SyndromeR01DK083952 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, WEN · 2010 to 2019
$3.0M
Hepatocyte Growth Factor and the Pancreatic Beta CrellR01DK067351 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GARCIA-OCANA, ADOLFO · 2004 to 2013
$2.3M
The Regulation of Human Hydroxysteroid Sulfotransferase by Nuclear Receptor RORR21ES019629 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI XIE, WEN · 2011 to 2012
$417k
NIDDK NIH HHS DK-083952NIDDK NIH HHS R01 DK067351NIDDK NIH HHS R01 DK083952NIEHS NIH HHS ES-019629NIEHS NIH HHS R21 ES019629
6 · The paper itself

Abstract

Estrogen sulfotransferase (EST), the enzyme responsible for the sulfonation and inactivation of estrogens, plays an important role in estrogen homeostasis. In this study, we showed that induction of hepatic Est is a common feature of type 2 diabetes. Loss of Est in female mice improved metabolic function in ob/ob, dexamethasone-, and high-fat diet-induced mouse models of type 2 diabetes. The metabolic benefit of Est ablation included improved body composition, increased energy expenditure and insulin sensitivity, and decreased hepatic gluconeogenesis and lipogenesis. This metabolic benefit appeared to have resulted from decreased estrogen deprivation and increased estrogenic activity in the liver, whereas such benefit was abolished in ovariectomized mice. Interestingly, the effect of Est was sex-specific, as Est ablation in ob/ob males exacerbated the diabetic phenotype, which was accounted for by the decreased islet β-cell mass and failure of glucose-stimulated insulin secretion in vivo. The loss of β-cell mass in ob/ob males deficient in Est was associated with increased macrophage infiltration and inflammation in white adipose tissue. Our results revealed an essential role of EST in energy metabolism and the pathogenesis of type 2 diabetes. Inhibition of EST, at least in females, may represent a novel approach to manage type 2 diabetes.

Indexed as

Adipose TissueAdiposityAnimalsCalorimetry, IndirectDiabetes Mellitus, Type 2Energy MetabolismFatty LiverFemaleGlucoseGlucose Clamp TechniqueHypothalamusInsulin ResistanceLiverMaleMiceMice, Obeseestrone sulfotransferaseGlucoseSulfotransferases

Identifiers

PMID22438574
PMCPMC3357292
OpenAlexW2151308509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.